ATE199596T1 - Diagnostisches reagenz für hepatitis c - Google Patents

Diagnostisches reagenz für hepatitis c

Info

Publication number
ATE199596T1
ATE199596T1 AT92117191T AT92117191T ATE199596T1 AT E199596 T1 ATE199596 T1 AT E199596T1 AT 92117191 T AT92117191 T AT 92117191T AT 92117191 T AT92117191 T AT 92117191T AT E199596 T1 ATE199596 T1 AT E199596T1
Authority
AT
Austria
Prior art keywords
hepatitis
diagnostic reagent
virus
antibody
infection
Prior art date
Application number
AT92117191T
Other languages
English (en)
Inventor
Tatsuo Miyamura
Izumu Saito
Shizuko Harada
Yoshikazu Honda
Original Assignee
Jp Agency Of Nat Inst Of Healt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jp Agency Of Nat Inst Of Healt filed Critical Jp Agency Of Nat Inst Of Healt
Application granted granted Critical
Publication of ATE199596T1 publication Critical patent/ATE199596T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT92117191T 1991-10-08 1992-10-08 Diagnostisches reagenz für hepatitis c ATE199596T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26082491A JP3158177B2 (ja) 1991-10-08 1991-10-08 Ｃ型肝炎診断薬

Publications (1)

Publication Number Publication Date
ATE199596T1 true ATE199596T1 (de) 2001-03-15

Family

ID=17353272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92117191T ATE199596T1 (de) 1991-10-08 1992-10-08 Diagnostisches reagenz für hepatitis c

Country Status (7)

Country Link
US (2) US5750331A (de)
EP (1) EP0537626B1 (de)
JP (1) JP3158177B2 (de)
AT (1) ATE199596T1 (de)
CA (1) CA2080213C (de)
DE (1) DE69231719T2 (de)
ES (1) ES2156858T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05344899A (ja) * 1992-06-11 1993-12-27 Kokuritsu Yobou Eisei Kenkyusho Ｃ型肝炎ウイルス外被タンパク質の産生法
US5846964A (en) * 1993-07-19 1998-12-08 Tokyo Tanabe Company Limited Hepatitis C virus proliferation inhibitor
SG71728A1 (en) * 1994-07-29 2000-04-18 Innogenetics Nv Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US8168771B2 (en) * 2005-01-31 2012-05-01 The Johns Hopkins University Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
CN102645534B (zh) * 2012-04-26 2015-08-12 杭州市萧山区第一人民医院 基于量子点编码微球芯片检测丙型肝炎病毒的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
KR0185373B1 (ko) * 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
NZ238681A (en) * 1990-06-25 1992-03-26 Univ Osaka Res Found Non-a, non-b hepatitis virus particles and their production
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
RO115446B1 (ro) * 1990-11-08 2000-02-28 Chiron Corp Procedeu de obtinere a asialoglicoproteinelor purificate provenind de la virusul hepatitei c
CA2070952A1 (en) * 1991-06-11 1992-12-12 Makoto Seki Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same

Also Published As

Publication number Publication date
EP0537626A1 (de) 1993-04-21
US5747241A (en) 1998-05-05
DE69231719D1 (de) 2001-04-12
EP0537626B1 (de) 2001-03-07
CA2080213A1 (en) 1993-04-09
US5750331A (en) 1998-05-12
ES2156858T3 (es) 2001-08-01
DE69231719T2 (de) 2001-07-12
CA2080213C (en) 2003-02-18
JPH05142231A (ja) 1993-06-08
JP3158177B2 (ja) 2001-04-23

Similar Documents

Publication Publication Date Title
FI20021626L (fi) Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi
DE69131149D1 (de) Synthetische Peptide, spezifisch zum Nachweis von gegen HCV gerichteten Antikörpern zur Diagnose der HCV-Infektion und zum Vorkommen davon als Impfstoffe
DK480889A (da) Non-a, non-b, hepatitisvirus-antigenpeptid, cdna kodende derfor, fremgangsmaade til detektering deraf og bakteriestamme indeholdende et saadant cdna
DE69022578D1 (de) Test für Hepatitis-C.
PT733069E (pt) Antigenios ctla-8 de primata purificados e reagentes relacionados
ATE141651T1 (de) Verfahren zum nachweis und zur identifizierung von nukleinsäure enthaltenden teilen
DE69027812D1 (de) Verfahren zur Zurichtung eines verbesserten Western-Blott-Immuntestverfahrens
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
FI935217A0 (fi) Basisk dissocieringsanalys
ATE191792T1 (de) Verfahren zur detektion von hepatitis c
DE69231719D1 (de) Diagnostisches Reagenz für Hepatitis C
DE69230812D1 (de) Verfahren zum Nachweis einer Rinderdiarrhoe- virusinfektion, für ein durch eine Infektion mit diesem Virus induziertes Eiweiss kodierende Nukleotidsequenz, sowie daraus abgeleitete rekombinante Eiweisse und Antigene
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ATE64783T1 (de) Nachweis von human-t-zellen-leukemievirus des typs-iii.
DE3789597D1 (de) Nachweis eines mit atmungskrankheiten verbundenen einzelstammes von chlamydia.
DE69119445D1 (de) Analysemethode für infektiöse Pferdeanämie-Viren (EIA-Virus)
ATE256704T1 (de) Antikörper und diagnostizierverfahren zur pestivirusdiagnose
ATE54758T1 (de) Verfahren zur bestimmung der antikoerper vom herpes-simplex-virus.
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
RU2002120241A (ru) Способ определения титров антител методом иммуноферментного анализа при диагностике вирусных инфекций
KR970058725A (ko) C형 간염 바이러스에 대한 항체의 정량적 역가 측정 방법